文献速递妇科产科

融合成像在晚期卵巢癌术前评估中的可行性与腹腔镜一致性

Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

融合成像在51例(98%)中可行,最终49例分析;融合成像的kappa值在多个PIV参数上高于单独CT或超声,中位检查时间20分钟。

要点

  • 融合成像在98%的患者中可行,中位检查时间20分钟。
  • 融合成像评估大网膜、肝表面、小网膜/胃/脾、结肠旁沟/前腹壁和膈肌受累与腹腔镜一致性均高于单独CT或超声。
  • 融合成像对肠道病变的一致性仍较低(kappa 0.469)。

核心结论

  • 融合成像在疑似卵巢或腹膜癌患者中可行,且与手术所见的一致性优于单独超声或CT。

研究设计与样本

  • 所有患者接受CT、超声和融合成像,以腹腔镜为参考标准,计算Cohen's kappa系数。
  • 最终49例纳入分析(2例未行腹腔镜,1例融合成像因技术原因不可行)。

主要发现

  • 以腹腔镜为参考标准,CT、超声和融合成像评估PIV参数的kappa值分别为:大网膜0.781、0.845、0.896;肝表面0.329、0.608、0.847;小网膜和/或胃和/或脾0.472、0.549、0.756;结肠旁沟和/或前腹壁0.385、0.588、0.795;膈肌0.385、0.497、0.657;肠道0.336、0.410、0.469。

临床怎么用

  • 融合成像可作为晚期卵巢癌术前评估腹腔内病变范围的补充工具,提高与腹腔镜所见的一致性。

局限性

  • 样本量较小(最终分析49例)。
  • 单中心前瞻性研究,可行性可能受操作者经验影响。
  • 融合成像对肠道病变的一致性仍较低(kappa 0.469)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fusion imaging is an emerging technique that combines real-time ultrasound examination with images acquired previously using other modalities, such as computed tomography (CT), magnetic resonance imaging and positron emission tomography. The primary aim of this study was to evaluate the feasibility of fusion imaging in patients with suspicion of ovarian or peritoneal cancer. Secondary aims were: to compare the agreement of findings on fusion imaging, CT alone and ultrasound imaging alone with laparoscopic findings, in the assessment of extent of intra-abdominal disease; and to evaluate the time required for the fusion imaging technique. METHODS: Patients with clinical and/or radiographic suspicion of advanced ovarian or peritoneal cancer who were candidates for surgery were enrolled prospectively between December 2019 and September 2020. All patients underwent a CT scan and ultrasound and fusion imaging to evaluate the presence or absence of the following abdominal-cancer features according to the laparoscopy-based scoring model (predictive index value (PIV)): supracolic omental disease, visceral carcinomatosis on the liver, lesser omental carcinomatosis and/or visceral carcinomatosis on the lesser curvature of the stomach and/or spleen, involvement of the paracolic gutter(s) and/or anterior abdominal wall, involvement of the diaphragm and visceral carcinomatosis on the small and/or large bowel (regardless of rectosigmoid involvement). The feasibility of the fusion examination in these patients was evaluated. Agreement of each imaging method (ultrasound, CT and fusion imaging) with laparoscopy (considered as reference standard) was calculated using Cohen's kappa coefficient. RESULTS: Fifty-two patients were enrolled into the study. Fusion imaging was feasible in 51 (98%) of these patients (in one patient, it was not possible for technical reasons). Two patients were excluded because laparoscopy was not performed, leaving 49 women in the final analysis. Kappa values for CT, ultrasound and fusion imaging, using laparoscopy as the reference standard, in assessing the PIV parameters were, respectively: 0.781, 0.845 and 0.896 for the great omentum; 0.329, 0.608 and 0.847 for the liver surface; 0.472, 0.549 and 0.756 for the lesser omentum and/or stomach and/or spleen; 0.385, 0.588 and 0.795 for the paracolic gutter(s) and/or anterior abdominal wall; 0.385, 0.497 and 0.657 for the diaphragm; and 0.336, 0.410 and 0.469 for the bowel. The median time needed to perform the fusion examination was 20 (range, 10-40) min. CONCLUSION: Fusion of CT images and real-time ultrasound imaging is feasible in patients with suspicion of ovarian or peritoneal cancer and improves the agreement with surgical findings when compared with ultrasound or CT scan alone. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Moro F, Bertoldo V, Avesani G, et al. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings. Ultrasound Obstet Gynecol. 2021. PMID: 33847427. doi:10.1002/uog.23650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。